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Hydrogen bondingThe positively charged side chains of cationic antimicrobial peptides are generally thought to provide the
initial long-range electrostatic attractive forces that guide them towards the negatively charged bacterial
membranes. Peptide analogs were designed to examine the role of the four Arg side chains in the cathelicidin
peptide tritrpticin (VRRFPWWWPFLRR). The analogs include several noncoded Arg and Lys derivatives that
offer small variations in side chain length andmethylation state. The peptides were tested for bactericidal and
hemolytic activities, and their membrane insertion and permeabilization properties were characterized by
leakage assays and ﬂuorescence spectroscopy. A net charge of +5 for most of the analogs maintains their high
antimicrobial activity and directs them towards preferential insertion into model bacterial membrane
systems with a similar extent of burial of the Trp side chains. However the peptides exhibit signiﬁcant
functional differences. Analogs with methylated cationic side chains cause lower levels of membrane leakage
and are associated with lower hemolytic activities, making them potentially attractive pharmaceutical
candidates. Analogs containing the Arg guanidinium groups cause more membrane disruption than those
containing the Lys amino groups. Peptides in the latter group with shorter side chains have increased
membrane activity and conversely, elongating the Arg residue causes slightly higher membrane activity.
Altogether, the potential for strong hydrogen bonding between the four positive Arg side chains with the
phospholipid head groups seems to be a determinant for the membrane disruptive properties of tritrpticin
and many related cationic antimicrobial peptides.0% hemolysis; ePC, egg-yolk
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There is currently a great interest in the therapeutic development
of cationic antimicrobial peptides to combat the problem of antibiotic
resistance in pathogenic bacteria. Many structure–function investi-
gations have been reported for antimicrobial peptides including
studies of the two naturally occurring Trp-rich peptides indolicidin
and tritrpticin. These two highly related cathelicidins are derived from
bovine and porcine sources [42]. The design of peptide analogs based
on their primary sequences has helped to gain insight into their
mechanism of action while also yielding more active peptides that do
not have the considerable hemolytic activities of the parent peptides.
One peptide named Omiganan, which is based on the primarysequence of indolicidin, has already been tested in various clinical
trials [10,20].
The sequences of the parent tridecapeptides, ILPWKWPWWPWRR-
NH2 and VRRFPWWWPFLRR for indolicidin and tritrpticin, respectively,
reveal that they eachhave a high content of Trp, Pro andArg residues. As
the major hydrophobic residues, the Trp side chains are expected to
embed themselves into the bacterialmembranes as the indole ring has a
strong preference for the interfacial region [3,4]. The role of the Pro
residues in tritrpticin and indolicidin is mainly structural, keeping the
peptides in a well-deﬁned turn–turn conformation when bound to a
membrane [23,26]. Interestingly, Pro-to-Ala substitutions allow these
two peptides to fold into α-helices upon membrane binding and for
tritrpticin, the replacement of only the ﬁrst Pro residue is sufﬁcient for
this dramatic change in secondary structure [7,27].
The Arg residues are thought to give selectivity to the peptides for
preferential interactions with negatively charged bacterial mem-
branes. Interestingly, Arg and Lys residues are not randomly
distributed in native antimicrobial peptides such as the defensins
[15]. Also, short Trp-rich antimicrobial hexapeptides have been found
through combinatorial chemistry, and these only contain Arg rather
than Lys residues [2]. For tritrpticin, switching the four guanidinium
groups of the Arg residues to the primary amines of Lys residues has
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however the Lys-derivative is transformed into a non-cytotoxic
peptide with little membrane disruptive activity [27,40]. Arginine
residues are ideal for making stable electrostatic and hydrogen bond
interactions with the negatively charged phosphodiester and phos-
phomonoester groups of phospholipids, nucleic acids and phosphor-
ylated proteins [17,19,38,41]. For antimicrobial peptides, these
interactions are thought to pull the phosphodiester phospholipid
head groups through the hydrophobic part of the membrane while
simultaneously dragging along hydrogen-bonded water molecules to
form a permeable toroidal pore [14,35].
In this work, functional and biophysical studies were carried out for
several tritrpticin peptide analogs. In these analogs, the four Arg
residues have all been substituted with unnatural and non-ribosomally
incorporated amino acids based on modiﬁed variations of the Arg and
Lys side chains. A few other antimicrobial peptide studies have also
employed amino acids with unnatural side chains or chemically altered
backbone structures [8,24,28,33,43,44]. Two of the analogs studied here
contain dimethylated arginine residues which until now have not been
incorporated into any antimicrobial peptides. The C-terminally ami-
dated analog of tritrpticin is used as the reference peptide in this study
because it has a slightly higher antimicrobial activity than the native
nonamidated peptide [27]. Moreover, this C-terminal substitution
occurs naturally in indolicidin [29]. After determining their relative
hydrophobicities by reverse phase high performance liquid chroma-
tography (RP-HPLC), the antimicrobial and hemolytic activities of all the
peptides were measured and their membrane binding and disruptive
properties were assessed using tryptophan ﬂuorescence spectroscopy
and calcein leakage assays.
2. Materials and methods
All peptides were purchased from Anaspec, Inc (San Jose, CA)where
they were synthesized using standard 9-ﬂuorenylmethyoxycarbonyl
(Fmoc) chemistry and puriﬁed by HPLC to N95% purity. Phospholipids
were purchased from Avanti Polar Lipids (Alabaster, AL).
2.1. RP-HPLC
The relative hydrophobicities of the peptides were determined by RP-
HPLC using a Waters μBondapak Phenyl column (3.9 mm×300mm;
Milford, MA). For each run, 100 μL of 5 μM test peptide were loaded and
eluted with a linear gradient of 0 to 100% acetonitrile in 0.05%
triﬂuoroacetic acid at a ﬂow rate of 1.0 mL/min for 34 min. Retention
times for each peptide were determined by A215 maximum peak heights.
2.2. Antimicrobial assays
The peptides were tested for microbicidal activities in duplicate
against Bacillus subtilis ATCC6633, Escherichia coli ML35 [13], and
Staphylococcus aureus 42D [12]. Test bacteria were incubated in a
microtiter plate at 105 colony-forming units/mL with peptides in a
range of two-fold dilutions in 100 μL of 10 mM phosphate buffer pH
7.0 supplemented with 1% (v/v) tryptic soy broth (TSB). After 2 h of
shaking at 37 °C, 10 μL aliquots were spread on blood agar plates for
overnight incubation at 37 °C. Activity was expressed as the 99.9%
Lethal Concentration (LC99.9), the concentration which had killed at
least 99.9% of the inoculum in the 2 h exposure period.
2.3. Hemolytic assays
Hemolytic assays were performed in duplicate using fresh human
red blood cells. The blood was collected in sodium citrate, added to
10 mM phosphate buffer, 130 mM NaCl, pH 7.4, and centrifuged at
200 ×g for 15 min. The erythrocyte-enriched pellets were washed
three times in the same buffer and a 1% (v/v) suspension wasprepared. This suspension was used to prepare quadruplicate
incubation mixtures in a microtiter plate with peptides in a range of
two-fold dilutions at 37 °C for 60 min. After the incubation period, the
mixtures were centrifuged at 1000 ×g for 5 min. The supernatants
were transferred to a new microtiter plate for spectrophotometric
readings at a wavelength of 540 nm to quantify hemoglobin
concentrations. 100% hemolysis was determined using a 1% Triton
X-100 positive control.
2.4. Tryptophan ﬂuorescence
As a measure of peptide interaction with membrane bilayers,
tryptophan ﬂuorescence spectra were acquired to follow the blue
shifts and intensity changes of the maximum emission wavelengths.
Subsequently, titrations with the uncharged quencher acrylamide
were carried out to gain information about the extent of burial of the
Trp indole rings into the membranes.
The samples consisted of 1 μM peptide in either a buffer control
(10 mMTris, 150 mMNaCl, 1 mM EDTA, pH 7.4), 30 μMePC:ePG (1:1)
large unilamellar vesicles (LUVs), or 30 μM ePC:cholesterol (2.5:1)
LUVs. LUVs were prepared by dissolving dried lipid ﬁlms in the buffer
by vortex followed by ﬁve freeze thaw cycles and thirteen passes
through the Avanti extrusion apparatus (Alabaster, AL) using 100 nm
Nuclepore membrane ﬁlters. The Varian Cary Eclipse ﬂuorimeter
(Mississauga, ONT) was equipped with a temperature controller,
which was used to keep the samples at 37 °C. Tryptophan was excited
at 280 nm (slit width 5 nm) with emission detection from 300 to
400 nm (slit width 10 nm). For the quenching titrations, incremental
volumes of a freshly prepared 4.0 M stock solution of acrylamide were
added to a ﬁnal concentration of 50 mM. From triplicates of these
titrations, Stern–Volmer constants (KSV's) were determined by
graphical analysis using the relationship: Fo/F=1+KSV [Q], where
Fo is the initial ﬂuorescence of the peptide in the absence of
acrylamide and F is the ﬂuorescence at a particular quencher
concentration [Q].
2.5. Calcein leakage
For the calcein leakage assays [18], LUVs were prepared by a
standard extrusion method [27]. The LUV compositions were 1:1 egg-
yolk phosphatidylcholine:egg-yolk phosphatidylglycerol (ePC:ePG)
to represent the negatively charged bacterial cytoplasmic membranes
and 2.5:1 ePC:cholesterol to represent mammalian membranes [27].
They were prepared with 70 mM calcein dye in leakage buffer
(10 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 7.4). After extrusion, free
calcein was removed from calcein-loaded LUVs by gel ﬁltration
chromatography with a Sephadex G-50 Superﬁne resin. The Ames
phosphate assay was used to determine lipid concentrations [1].
Leakage experiments were performed in duplicate on a Varian
Cary Eclipse ﬂuorimeter equipped with a Peltier temperature control
device set at 37 °C. The Cary Eclipse Kinetics program was used to
follow the calcein ﬂuorescence, with respective excitation and
emission wavelengths of 490 nm and 520 nm and both slit widths
at 5 nm. The baseline calcein ﬂuorescence of 10 μM lipid LUVs was
monitored for 1 min prior to the addition of the corresponding
amount of peptide for the appropriate peptide:lipid ratio tested.
Peptide-induced leakage was followed for 10 min, after which Triton
X-100 was added to a ﬁnal concentration of 0.1% to determine the
ﬂuorescence signal for 100% LUV permeabilization.
3. Results
3.1. Peptide design
All of the peptides studied here are amidated at the C-terminus.
This modiﬁcation increases the overall positive charge of the peptides
Table 1
Relative peptide hydrophobicities as measured by analytical RP-HPLC.
Peptide Retention time (min)
Tritrp 20.54
CitTritrp 22.68
AdmRTritrp 21.25
SdmRTritrp 21.25
HRTritrp 21.53
KTritrp 19.98
OrnTritrp 19.91
DabTritrp 19.92
DmKTritrp 20.71
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analogs, the four Arg residues of the amidated Tritrp peptide are
substituted with either an Arg derivative, Lys, or a Lys derivative
(Fig. 1). These are relatively small alterations, none of which are
expected to change the secondary structures of the analogs. CitTritrp
has a citrulline substitution that effectively removes all the positive
charges from the peptide except for the terminal amino group.
AdmRTritrp and SdmRTritrp incorporate asymmetric and symmetric
dimethylated Arg residues which have reduced capabilities as
hydrogen bond donors. HRTritrp contains homoarginine, an Arg
variant that is longer by one methylene group. Two of the Lys variant-
substituted peptides also have modiﬁed side chain lengths. Ornithine,
the distinguishing residue of OrnTritrp, is shorter than lysine by one
methylene group, and diaminobutyric acid, the substituted residue in
DabTritrp, is shorter by two carbon chain lengths. DmKTritrp contains
dimethylated lysines, which also would have reduced hydrogen
bonding capabilities compared to Lys.
3.2. Peptide hydrophobicity
Retention times from RP-HPLC runs were measured to conﬁrm the
predicted relative hydrophobicities of the analogs (Table 1). Due to
the loss of charge, CitTritrp has the highest retention time of the
peptides and is therefore the most hydrophobic. With the Lys side
chain being slightly less hydrophobic than the Arg side chain [37],
KTritrp has a lower retention time than Tritrp. Analogs withFig. 1. Chemical structures of the modiﬁed arginine and lysine residues incorporated
into the X positions of the tritrpticin sequence (top). Names of the resulting analogs are
given above the structures.methylated side chains show higher hydrophobicity than the
corresponding peptides containing unmethylated Arg or Lys residues.
Analogs with chain length variations generally follow the expected
trend of longer side chains adding to a peptide's hydrophobicity,
however OrnTritrp and DabTritrp have almost indistinguishable
retention times.
3.3. Antimicrobial activities
All the analogs were tested for bactericidal activity against strains
of B. subtilis, S. aureus, and E. coli. For most of the peptides, their
activities remained intact or were slightly improved when compared
to Tritrp (Table 2).With its uncharged citrulline residues, CitTritrp has
reduced antimicrobial potency, although the loss of activity is not
complete. The C-terminal amide maintains the positive charge of the
peptide with a net charge of +1. The remaining peptides, featuring
variations in side chain lengths or methylation state in the positively
charged residues, all retain their activities. They all have a net charge
of +5 which allows us to ascribe any changes in their behavior to
their unique chemistries.
3.4. Hemolytic activity
Most of the Arg substituted peptides have a reduced hemolytic
activity in the range of concentrations tested (Fig. 2). These include
CitTritrp, AdmRTritrp, SdmRTritrp, KTritrp, OrnTritrp and DmKTritrp.
There are two peptides that retain the signiﬁcant hemolytic activity of
Tritrp. HRTritrp, with the elongated homoarginine residues, is in fact
even more hemolytic, having an effective concentration for 50% lysis
(EC50) at around 10 μM compared to 30 μM for Tritrp. DabTritrp, with
the shortened diaminobutyric acid residues, is slightly lower in
hemolytic activity with an EC50 of 60 μM.
3.5. Tryptophan ﬂuorescence
The hydrophobicity of the environment of Trp side chains can be
qualitatively measured by following the blue shift of the maximum
ﬂuorescence emission wavelengths compared to reference valuesTable 2
Antimicrobial activities of the Arg-substituted Tritrp peptides.
Peptide 99.9% Lethal Concentration, LC99.9 (μM)
B. subtilis S. aureus E. coli
Tritrp 0.9 1.9 0.9
CitTritrp 7.5 30 30
AdmRTritrp b0.45 1.9 3.8
SdmRTritrp b0.45 1.9 0.45
HRTritrp 0.45 0.9 0.9
KTritrp b0.45 1.9 0.45
DmKTritrp b0.45 1.9 b0.45
OrnTritrp 0.45 0.9 0.9
DabTritrp 0.9 0.9 0.9
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Fig. 2. Hemolytic activity curves of the Tritrp analogs. Peptides are as follows: A) Arg-
substituted peptides with Arg derivatives: Tritrp (black solid line), CitTritrp (gray),
AdmRTritrp (short dashed), SdmRTritrp (long dashed), HRTritrp (dotted); and B) Arg-
substituted peptides with Lys derivatives KTritrp (gray), DmKTritrp (short dashed),
OrnTritrp (long dashed), DabTritrp (dotted). Negative hemolysis values are due to
subtraction of the negative control of red blood cell incubations representing 0%
hemolysis. Experiments were performed in quadruplicate.
Table 3
Blue shifts in maximum emission wavelengths of Trp ﬂuorescence in 1:1 ePC:ePG and
2.5:1 ePC:cholesterol LUVs.
Peptide Ref.
wavelength
in buffer
(nm)
Shifts (nm)
ePC:ePG ePC:cholesterol
Tritrp 351 14 2
CitTritrp 351 2 1
AdmRTritrp 350 14 1
SdmRTritrp 350 13 1
HRTritrp 352 14 1
KTritrp 351 13 0
OrnTritrp 351 13 1
DabTritrp 351 13 1
DmKTritrp 349 13 2
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Fig. 3. Stern–Volmer (KSV) constants of the Arg-substituted tritrpticin analogs as
determined from the acrylamide quenching experiments in the following environ-
ments: aqueous buffer (blank bars), ePC:ePG LUVs (gray), and ePC:cholesterol LUVs
(striped).
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of membranes, the indole side chains will emit ﬂuorescence signals at
shorter wavelengths if they become exposed to the hydrophobic core
and/or interfacial regions of the membranes. Here, we have measured
Trp ﬂuorescence with two model membrane systems; negatively
charged LUVs containing an ePC:ePG mixture and zwitterionic LUVs
containing an ePC:cholesterol mixture to resemble the bacterial and
mammalian membranes, respectively [16]. As shown in Table 3,
almost all of the peptides exhibit similar blue shifts in the presence of
ePC:ePG LUVs, with the exception of CitTritrp, which is the only
peptide with signiﬁcantly lower antimicrobial activity. With ePC:
cholesterol LUVs, very small-to-nonexistent shifts are observed. These
data illustrate that all the peptides except CitTritrp preferentially
insert into model membranes with negatively charged phospholipid
headgroups.
As an extension of the blue shift ﬂuorescence spectroscopy results,
the burial of the Trp residues into the membranes was determined for
each peptide by titration with acrylamide, a polar quencher. Because
of the membrane environments used in these studies, this uncharged
molecule was selected as a quenching agent rather than commonly
used ionic quenchers such as Cs+ and I−. The results obtained with
the latter two agents are often markedly inﬂuenced by the proximal
charges [30]. The Trp ﬂuorescence intensity changes were analyzed
through Stern–Volmer plots from which the quenching constants
(KSV's) can be determined. These give an indication as to the extent of
solvent exposure for the Trp side chains of the peptides. The results
shown in Fig. 3 corroborate the blue shifts observed, with the Trp
residues of all the peptides embedding themselves considerably into
ePC:ePG membranes. As expected, CitTritrp experiences much less of
a difference in KSV value between aqueous buffer and with ePC:ePG
LUVs. The latter value is considerably lower than those associatedwith the other peptide analogs in buffer, indicating that the Trp side
chains of the free CitTritrp peptide in aqueous solution may be
somewhat shielded from the bulk solvent. Such an effect could arise
through dimerization of the peptide in aqueous solution, however
there is no accompanying shift in the emission maximum. In the
presence of ePC:cholesterol LUVs, all peptides show slightly dimin-
ished KSV values compared to those in the buffer conditions alone,
however these differences are not signiﬁcant given the size of the
error in the titrations.
Altogether, the Trp ﬂuorescence results show that all of the active
antimicrobial peptides seem to be able to partially penetrate ePC:ePG
membranes while with ePC:cholesterol membranes, there is little to
no interactions with the peptides.
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Fig. 5. Calcein leakage results for the Tritrp analogs using zwitterionic ePC:cholesterol
(2.5:1) LUVs to represent mammalian membranes. Peptides are as follows: A) Arg-
substituted peptides with Arg derivatives: Tritrp (black solid line), CitTritrp (gray),
AdmRTritrp (short dashed), SdmRTritrp (long dashed), HRTritrp (dotted); and B) Arg-
substituted peptides with Lys derivatives: KTritrp (gray), DmKTritrp (short dashed),
OrnTritrp (long dashed), DabTritrp (dotted).
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To measure their membrane lytic activities, the peptides were
assayed for intravesicular calcein leakage using the model bacterial
andmammalian membranes of 1:1 ePC:ePG and 2.5:1 ePC:cholesterol
LUVs, respectively. With the former membrane system, most of the
peptides cause signiﬁcant membrane disruption (Fig. 4). Tritrp causes
similar levels of leakage compared to HRTritrp, however decreased
levels are observed with the peptides containing methylated Arg
residues (AdmRTritrp and SdmRTritrp) and even more so with the
uncharged citrulline residues (CitTritrp). KTritrp causes slightly less
leakage than Tritrp, especially at peptide/lipid ratios lower than 1:20.
The two peptides with a shorter length than the Lys side chains,
OrnTritrp and DabTritrp, show little difference compared to KTritrp,
while DmKTritrp, which has dimethylated Lys side chains, is
considerably less membrane active.
The leakage assay results obtained with ePC:cholesterol LUVs
(Fig. 5) generally agree with the hemolysis results. All of the peptides
cause low levels of leakage, suggesting decreased interactions with
these neutral membranes. Interestingly, Tritrp, HRTritrp, and Dab-
Tritrp are the only peptides causing considerable membrane disrup-
tion in this system and this correlates well with the signiﬁcant
hemolytic activities measured for these peptides.
4. Discussion
In the class of naturally occurring antimicrobial peptides with an
unusual composition of regular amino acids, a high content of Trp and
Arg residues is a recurring theme, especially for peptides that are less
than 15 amino acids in length [3,11,25,32,36]. A similar trend is seen
in short combinatorially obtained hexapeptides [2]. The peptide
analogs studied here were designed to evaluate the roles of the Arg
residues in tritrpticin. Amino acid derivatives were introduced thatA)
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Fig. 4. Calcein leakage results for the Tritrp analogs using negatively charged ePC:ePG
LUVs to represent bacterial membranes. Peptides are as follows: A) Arg-substituted
peptides with Arg derivatives: Tritrp (black solid line), CitTritrp (gray), AdmRTritrp
(short dashed), SdmRTritrp (long dashed), HRTritrp (dotted); and B) Arg-substituted
peptides with Lys derivatives: KTritrp (gray), DmKTritrp (short dashed), OrnTritrp
(long dashed), DabTritrp (dotted).are not usually incorporated by ribosomal synthesis into peptides or
proteins. Introduction of these groups could also potentially help to
increase the resistance of the peptides to degradation from secreted
bacterial or serum proteolytic enzymes, should any of them be
developed further for clinical use. Interestingly, the noncoded amino
acid ornithine has been found occasionally in some defensins as a
hydrolysis product of an ADP-ribosylated arginine [31]. Modiﬁed Arg
residues have been incorporated into short antimicrobial peptides
previously [33], however this was done in a manner where
hydrophobic groups were added to the positively charged side chains
and this study did not explore the roles of the Arg residues in the
antimicrobial activity speciﬁcally. Analogs similar to our peptides
have been previously studied with Arg substitutions to modiﬁed Arg
or Lys residues using the β-sheet defensin HNP-1 peptide as the
parent antimicrobial peptide [44]. However, this study did not include
analogs with the substituted asymmetric or symmetric dimethyl Arg
residues. From the work with the HNP-1 analogs, it was concluded
that the Arg side chains were of optimal chain lengths for the
antimicrobial activity of the 30-aa long defensin. By contrast, most of
the Tritrp analogs studied here retain high antimicrobial activities,
and so the overall sequence of tritrpticin must be resilient enough to
overcome the differences in chain lengths or methylation of the
cationic residues.
The ﬂuorescence spectroscopy data show that almost all of the
peptide analogs have their Trp residues buried signiﬁcantly into the
negatively charged model membranes, mimicking bacterial mem-
branes, and much less so with the zwitterionic cholesterol-containing
membranes mimicking eukaryotic membranes. The low degree of Trp
burial for CitTritrp into the ePC:ePG membranes is primarily a
consequence of the loss of the four positive charges at the Arg
positions.
Even though most of the peptides are able to embed themselves
into the hydrophobic interiors of membranes, the calcein leakage
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analogs can disrupt the integrity of the lipid bilayers. For these Arg-
substituted peptides, the membrane-disruptive properties seem to be
governed by the number of potential hydrogen bonds the four side
chains in the Arg positions can make with the phospholipid
backbones. In molecular dynamics simulations of various antimicro-
bial peptides binding to membranes, short distances imply that
hydrogen bonds are formed between donor groups of the Arg and Lys
side chains and the acceptor phosphodiester head groups of
phospholipids esters [9,21]. The three nitrogens of the Arg guanidi-
nium group can act as highly directional hydrogen bond donors
compared to the single primary amine of the Lys side chain, and
therefore Tritrp is more membrane active than KTritrp.
While the low antimicrobial activity in CitTritrp can be attributed
to the loss of charge, its low hemolytic activity is more difﬁcult to
explain; as the most hydrophobic peptide in this series, this analog
would be expected to have the highest hemolytic activity [34]. The
replacement of one H-bond donating amino group from arginine to
form the citrulline side chain therefore seems to be responsible for the
loss of leakage activity for the model mammalian membrane and, by
extension, the hemolytic activity. The three peptides with methylated
cationic residues, AdmRTritrp, SdmRTritrp, and DmKTritrp, all have
decreased membrane permeabilizing activity due to the loss in their
capacity for hydrogen bonding as well. It cannot be ruled out that the
steric effects of the methyl group substitutions in these analogs may
also contribute to decrease membrane interactions.
The two peptides with shorter side chains than Lys, OrnTritrp and
DabTritrp, are less hydrophobic than KTritrp and accordingly cause
less leakage with the ePC:ePG LUVs. With the ePC:cholesterol LUVs,
however, the former peptides are more membrane disruptive.
Furthermore, we observed that DabTritrp is considerably more
hemolytic than KTritrp and OrnTritrp. A possible explanation for
these results may be due to a difference in how the peptides ﬁt into
the mammalian membrane. The presence of cholesterol in these
membranes generally increases the order and area of the lipid acyl tail
region without adding much space in the headgroup region. The
shorter side chains of DabTritrp may be able to ﬁt better into these
cholesterol-induced gaps, which would decrease the area covered by
the peptide on the membrane surface compared to KTritrp. This
would then allow for tighter association between peptides on the
mammalian membrane, leading to higher disruptive activity.
The longer side chains of HRTritrp compared to Tritrp increase the
former peptide's hydrophobicity, and this explains its slightly higher
hemolytic and membrane disruptive activities regardless of lipid
composition.
The positively charged side chains are presumably involved in
simultaneous hydrogen bonds with water molecules to disrupt the
membrane via water-ﬁlled toroidal pores. Hydrogen bonding be-
tween the peptide and the lipid head groups may also play a part in
lipid clustering on the bacterial membrane [5], a distinct mode of
membrane action from toroidal pore formation. As demonstrated
recently for highly cationic antimicrobial peptides [6,22], this mode of
action involves the peptide-induced segregation of anionic lipids from
zwitterionic lipids. This lipid phase separation leads to overall changes
in the stability of the bacterial membrane that may not necessarily be
reﬂected by the calcein leakage assays.
The results obtained here reinforce some of the previous work
done for Tritrp analogs containing substitutions with common amino
acids where membrane leaking ability from ePC:cholesterol LUVs was
shown to correlate with the hemolytic activity [27]. There are also
many non-hemolytic Arg-substituted peptides that adopt the turn–
turn structure of native triptrpticin upon membrane binding. As
mentioned, hemolytic activity seems to be determined by the possible
number of contacts a peptide can make with the membrane, which
would affect the afﬁnity of this interaction. However, subtle steric
effects may also play a part in how the peptides adsorb into themembrane, depending on its composition. Regardless of membrane
disruptive ability, all of the highly cationic peptides studied here
retain their broad bactericidal activities. As in previous studies with
tritrpticin, this points to additional possible mechanisms of action
beyond cytoplasmic membrane disruption for certain analogs [27,39].
Unlike these studies however, the peptides here do not show
complete transformations from a highly membrane active peptide
to a membrane non-disruptive peptide in a membranous environ-
ment. Instead, the different degrees of membrane disruptive ability
and structure shown by the antimicrobial Arg-analog peptides
demonstrate that tritrpticin is not solely a membrane disrupting
peptide and may well use a combination of mechanisms of action.
Furthermore, other phosphate-containing targets for tritrpticin such
as lipopolysaccharides and nucleic acids may have to be ruled out
since the differences in the analogs' hydrogen bonding capacities are
not reﬂected in differences in antimicrobial activity.
In summary, several peptide analogs were designed and tested to
investigate the role of theArg side chains of tritrpticin in its hemolytic and
antimicrobial activity. Several of these peptides have increased therapeu-
tic values, with slight increases in antimicrobial activity combined with
signiﬁcant losses in thehemolytic activity compared to theparentpeptide.
The results here show that the hydrogen bonding properties of the four
Arg residues play major functional roles in membrane disruptive abilities
of the peptides, in addition to the electrostatic interactions that initially
attract the peptides to the membranes.
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